Nuvectra Quick Ratio (NVTR) starting from the second quarter 2019 to second quarter 2018, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Nuvectra Corp  (NVTR)

Nuvectra's Quick Ratio

NVTR's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2019, Quick Ratio fell to 3.77 below Nuvectra Corp average.

Within Medical Equipment & Supplies industry 43 other companies have achieved higher Quick Ratio than Nuvectra in second quarter 2019. While Quick Ratio total ranking in the second quarter 2019 has deteriorated compared to the prior quarter from 802 to 1167.

Explain Quick Ratio?
How much Cash & cash equivalents NVTR´s has?
What are NVTR´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NVTR Quick Ratio (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1		 (Dec 31 2018)
Q4		 (Sep 30 2018)
Q3		 (Jun 30 2018)
Q2
Y / Y Current Liabilities Change 25.65 % 22.92 % 80.29 % 16.96 % 53.82 %
Y / Y Cash & cash equivalent Change 59.66 % 50.99 % 252.35 % 73.39 % -32.34 %
Quick Ratio MRQ 3.77 5.33 4.83 6.52 2.97
NVTR's Total Ranking # 1167 # 802 # 496 # 450 # 826
Seq. Current Liabilities Change 21.15 % -25.73 % 31.56 % 6.14 % 18.52 %
Seq. Cash & cash equivalent Change -14.2 % -18.07 % -2.57 % 133.12 % -18.86 %



Quick Ratio second quarter 2019 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 44
Healthcare Sector # 422
Overall Market # 1167


Quick Ratio Statistics
High Average Low
14.57 6.03 2.47
(Apr 01 2016)   (Dec 31 2017)




Financial Statements
Nuvectra's Current Liabilities $ 18 Millions Visit NVTR's Balance sheet
Nuvectra's Cash & cash equivalent $ 70 Millions Visit NVTR's Balance sheet
Source of NVTR's Sales Visit NVTR's Sales by Geography


Cumulative Nuvectra's Quick Ratio

NVTR's Quick Ratio for the trailling 12 Months

NVTR Quick Ratio

 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months		 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months		 (Jun 30 2018)
12 Months
Y / Y Current Liabilities TTM Growth 34.76 % 41.53 % 40.39 % 8.88 % 9.76 %
Y / Y Cash & cash equivalent TTM Growth 90.93 % 58.81 % 22.58 % -18.49 % -37.7 %
Quick Ratio TTM 5.04 4.93 4.72 4.2 3.56
Total Ranking TTM # 4310 # 4321 # 506 # 554 # 329
Seq. Current Liabilities TTM Growth 5.71 % 4.5 % 16.9 % 4.36 % 11.02 %
Seq. Cash & cash equivalent TTM Growth 7.99 % 9.19 % 31.23 % 23.37 % -10.17 %

Quick ratio ranking by company, industry and sector >> Back to NVTR Financial Strength Comparisons >> Go to Compare NVTR Quick Ratio to its Competitors

On the trailing twelve months basis NVTR Cash & cash equivalent soared by 59.66 % in Q2 2019 year on year, faster than Current Liabilities, this led to increase in in Nuvectra's Quick Ratio to 5.04, above NVTR average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 179 other companies have achieved higher Quick Ratio than Nuvectra. While Quick Ratio overall ranking has improved so far to 4310, from total ranking during the twelve months ending first quarter 2019 at 4321.

Explain Quick Ratio?
How much Cash & cash equivalents NVTR´s has?
What are NVTR´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 180
Healthcare Sector # 855
Within the Market # 4310


trailing twelve months Quick Ratio Statistics
High Average Low
7.38 5.03 3.2
(Sep 30 2017)   (Jun 30 2018)




Companies with similar Quick Ratio in the quarter ending Jun 30 2019, within Medical Equipment & Supplies Industry Quick RatioJun 30 2019 MRQ Cash & cash equivalentJun 30 2019 MRQ Current Liabilities
Si bone inc   10.06 $ 103.276  Millions$ 10.268  Millions
Insulet Corporation  9.88 $ 309.748  Millions$ 31.352  Millions
Novocure Limited  9.46 $ 284.584  Millions$ 30.069  Millions
Harpoon Therapeutics Inc   9.23 $ 133.884  Millions$ 14.507  Millions
Utah Medical Products Inc  8.61 $ 32.880  Millions$ 3.821  Millions
Nevro Corp   8.46 $ 233.931  Millions$ 27.663  Millions
Shockwave Medical Inc   8.13 $ 125.137  Millions$ 15.400  Millions
Catheter Precision Inc   7.69 $ 48.388  Millions$ 6.295  Millions
Streamex Corp   7.31 $ 10.334  Millions$ 1.414  Millions
Apyx Medical Corp  7.26 $ 67.360  Millions$ 9.279  Millions
Atrion Corporation  6.87 $ 75.197  Millions$ 10.942  Millions
Iradimed Corporation  6.68 $ 32.422  Millions$ 4.857  Millions
Axogen inc   6.36 $ 103.063  Millions$ 16.214  Millions
Biolife Solutions Inc   6.34 $ 19.617  Millions$ 3.093  Millions
Transmedics Group Inc   6.33 $ 96.237  Millions$ 15.202  Millions
Electrocore Inc   6.11 $ 41.134  Millions$ 6.730  Millions
Invivo Therapeutics Holdings Corp   6.09 $ 9.902  Millions$ 1.627  Millions
Masimo Corp  5.99 $ 588.784  Millions$ 98.304  Millions
Perspective Therapeutics Inc   5.92 $ 5.326  Millions$ 0.899  Millions
Intersect Ent Inc   5.86 $ 93.472  Millions$ 15.953  Millions
Abiomed Inc   5.79 $ 486.672  Millions$ 84.008  Millions
Soliton Inc   5.66 $ 11.187  Millions$ 1.976  Millions
Neuronetics Inc   5.57 $ 89.644  Millions$ 16.091  Millions
Inogen Inc   5.52 $ 256.149  Millions$ 46.362  Millions
Soleno Therapeutics Inc  5.43 $ 15.503  Millions$ 2.855  Millions
Orasure Technologies Inc  4.91 $ 147.013  Millions$ 29.951  Millions
Glaukos Corp  4.85 $ 150.394  Millions$ 31.001  Millions
Myomo Inc   4.64 $ 6.669  Millions$ 1.436  Millions
Tactile Systems Technology Inc   4.26 $ 45.464  Millions$ 10.667  Millions
Valion Bio Inc   4.08 $ 4.674  Millions$ 1.145  Millions

Date modified: 2026-09-08T15:09:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.